Key Takeaways & Executive Findings
- •• • HOF-101 and HOF-102 achieved drug loading capacities of 27% and 29.8%, respectively, enabling reduced therapeutic dosages and minimized adverse effects—critical for clinical translation where off-target toxicity remains a primary failure mode. • • HOF-TATB exhibited an ultrasound activation threshold of 0.51 MPa with only 5.5% premature drug release, demonstrating superior temporal resolution and safety margins for deep-tissue neuromodulation where unintended activation can cause severe neurological side effects. • • Release kinetics correlated directly with peak ultrasound pressure and material Ecohesive values, providing a quantitative design rule for tuning mechanoresponsive HOFs—this replaces empirical trial-and-error with predictive engineering, accelerating development cycles. • • The platform successfully encapsulated deschloroclozapine, dopamine, and procaine, proving versatility across chemically diverse payloads; this broadens applicability from psychiatric neuromodulation to neurotransmitter replacement and local anesthesia, addressing multiple unmet clinical needs.
China Clean Energy & Battery Radar
Get verified English translations, SEM micrographs & open-access PDF alerts from China's leading state key laboratories delivered to your inbox every Monday at 08:00 EST.
Abstract
The precise spatiotemporal regulation of mechanochemical activation within deep tissue remains a critical unmet challenge in precision medicine. This study reports an ultrasound-programmable drug delivery platform based on hydrogen-bonded organic frameworks (HOFs), integrating mechanochemical fracture dynamics with ultrasonic wave propagation theory to establish a predictive model for rational design. A proof-of-concept nanocrystalline system encapsulating clozapine N-oxide (CNO) within an optimized HOF matrix achieved focused ultrasound (FUS)-gated payload release in vivo, enabling spatiotemporal control of engineered G protein-coupled receptor (GPCR) activation in the ventral tegmental area (VTA) of murine models. Experimental validation across multiple HOFs demonstrated drug loading capacities of 27% (HOF-101) and 29.8% (HOF-102), with minimal premature release (HOF-TATB: 5.5% pre-release). Release kinetics correlated with peak ultrasound pressure and material Ecohesive values; HOF-TATB exhibited an activation threshold of 0.51 MPa and superior temporal resolution. The platform successfully loaded diverse therapeutics including deschloroclozapine, dopamine, and procaine. These findings establish foundational principles for non-invasive, ultrasound-programmable HOF architectures, representing a paradigm shift in precision molecular therapeutics.
1. Introduction
Existing drug delivery systems for deep-tissue neuromodulation rely on systemic administration or invasive surgical implantation, both of which suffer from poor spatiotemporal control, significant off-target effects, and limited patient compliance. While focused ultrasound (FUS) has been explored as a non-invasive trigger, no mechanoresponsive material system has yet combined robust theoretical frameworks with clearly defined ultrasound activation parameters, leaving a critical gap between proof-of-concept and clinical deployment.
This study addresses the bottleneck by engineering hydrogen-bonded organic frameworks (HOFs) that undergo mechanochemical fracture under FUS, releasing encapsulated therapeutics with precise spatiotemporal control. By integrating fracture dynamics with ultrasonic propagation theory, the authors developed a predictive model that correlates peak ultrasound pressure and material Ecohesive values with release kinetics. The resulting platform achieved 27–29.8% drug loading, minimal premature release (5.5% for HOF-TATB), and an activation threshold of 0.51 MPa, enabling in vivo GPCR activation in the murine ventral tegmental area. This work establishes a quantitative framework for designing ultrasound-programmable HOFs, overcoming the empirical limitations of prior delivery systems.
Loading authentic research manuscript (Pages 1–5)...
Wei Chen, Peng Li (2025). Ultrasound-Programmable Hydrogen-Bonded Organic Frameworks for Precision Drug Delivery and Neuromodulation. SCIENCE CHINA Materials. https://doi.org/10.1007/s40843-025-3340-x
Research & Educational Purpose Only: The translations, structured abstracts, analytical annotations, and data reports provided by SinoGreenTechare intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoGreenTech claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the failure mechanism of HOFs under repeated ultrasound cycling, and how does it affect long-term stability?
Repeated ultrasound cycling induces cumulative mechanochemical fracture, leading to progressive framework degradation. While HOF-TATB showed only 5.5% premature release, extended cycling beyond the activation threshold of 0.51 MPa may cause irreversible structural collapse, reducing encapsulation efficiency and causing burst release. Long-term stability data beyond the reported in vivo timeframe are lacking, posing a risk for chronic applications.
How does the cost of HOF synthesis and ultrasound equipment compare to established drug delivery technologies like liposomes or polymer nanoparticles?
HOF synthesis relies on self-assembly of organic linkers, which can be cost-competitive at scale, but purification and nanocrystal size control add expense. Focused ultrasound systems require capital investment (typically $50,000–$200,000) and specialized operators. In contrast, liposomal formulations benefit from mature manufacturing infrastructure. A detailed cost-benefit analysis is absent, but for high-value neuromodulation therapies, the precision may justify the premium.
What are the scalability bottlenecks for manufacturing HOF nanocrystals with consistent drug loading and size distribution?
Scaling HOF nanocrystals from bench to industrial production faces challenges in controlling nucleation and growth during self-assembly, which affects batch-to-batch reproducibility of loading capacity (e.g., 27% vs. 29.8% for HOF-101 and HOF-102). Maintaining narrow size distribution for uniform ultrasound response requires precise solvent, temperature, and mixing control. Continuous flow synthesis may offer a path, but yields and throughput remain unproven at commercial scale.
What is the in vivo degradation profile and clearance mechanism of HOFs, and are there long-term toxicity concerns?
The paper does not provide detailed degradation kinetics or clearance pathways. HOFs are held together by hydrogen bonds, which may hydrolyze under physiological conditions, releasing organic linkers that require renal or hepatic clearance. Without chronic toxicity studies, the accumulation of linker molecules or residual nanocrystals in the ventral tegmental area could pose neuroinflammatory risks. This gap must be addressed before clinical translation.
How does the ultrasound activation threshold of 0.51 MPa translate to human skull penetration and targeting accuracy for deep brain regions?
The 0.51 MPa threshold was determined in murine models, where skull attenuation is minimal. In humans, the skull attenuates ultrasound by 30–50%, requiring higher incident pressures to achieve 0.51 MPa at depth, which may exceed safety limits (FDA guidelines: ISPTA < 720 mW/cm²). Targeting accuracy in the ventral tegmental area (depth ~7 cm) demands precise phase correction; without transcranial focusing, off-target activation could occur. Human feasibility remains unvalidated.
Related Chinese Research & Cross-Citations
Ammonium Vanadate Cathodes in Aqueous Zinc-Ion Batteries: Design Strategies and Research Progress
Aqueous zinc-ion batteries (AZIBs) offer a compelling combination of high safety, environmental compatibility, and abundant zinc resources, positioning them as viable candidates for grid-scale energy storage. Their practical deployment, however, is constrained by cathode materials that suffer from structural degradation, sluggish Zn2+ diffusion, and inadequate electronic conductivity. Ammonium vanadates (AVOs) have emerged as high-performance cathodes owing to their layered or tunneled frameworks, which accommodate reversible Zn2+ (de)intercalation with diffusion coefficients superior to conventional vanadium oxides. This review systematically examines recent advances in AVO cathodes for AZIBs, correlating morphological variations—including nanowires, nanobelts, and microflowers—with electrochemical characteristics. The analysis establishes structure–performance relationships that govern capacity retention, rate capability, and cycling stability. Key optimization strategies are critically assessed: defect engineering to enhance electronic conductivity and active site density, interlayer spacing modulation via pre-intercalated cations or structural water to facilitate Zn2+ transport, and composite construction with conductive carbonaceous or polymeric matrices to mitigate dissolution and improve mechanical integrity. Despite these advances, challenges persist in achieving long-term cycling stability (>10,000 cycles) and high areal mass loading (>10 mg cm-2) required for commercial viability. The review concludes by outlining future research directions, including operando characterization of degradation mechanisms and scalable synthesis routes for AVO cathodes in practical AZIB configurations.
Microenvironment-responsive therapeutic platforms: Innovations for spinal cord injury repair
Spinal cord injury (SCI) remains a formidable clinical challenge due to the complex, dynamic lesion microenvironment that impedes axonal regeneration and functional recovery. This highlight examines a microenvironment-responsive therapeutic platform integrating microneedle delivery, ferroptosis modulation, and hydrogen therapy. The platform leverages the pathological hallmarks of SCI—oxidative stress, iron dyshomeostasis, and lipid peroxidation—to achieve spatiotemporally controlled cargo release. By combining microneedle arrays for minimally invasive intraparenchymal administration with hydrogen-releasing biomaterials, the system addresses the dual bottlenecks of poor drug penetration across the blood-spinal cord barrier and insufficient neutralization of reactive oxygen species. Ferroptosis inhibition is achieved through iron chelation and glutathione peroxidase 4 (GPX4) stabilization, while hydrogen gas scavenges hydroxyl radicals and peroxynitrite. This multimodal strategy attenuates secondary injury cascades, reduces glial scar formation, and promotes neural stem cell differentiation. The work is supported by the National Natural Science Foundation of China (82574518) and the Talent Cultivation Project of Paring Academicians with Young Talents in higher education institutions in Zhejiang. The authors declare no conflict of interest. This highlight underscores the translational potential of microenvironment-responsive platforms for SCI repair, emphasizing the need for rigorous preclinical validation and scalable manufacturing.
Dual-Site Adsorption over Phosphorus-Doped Copper Oxide for Efficient CO2 Electroreduction to Ethylene
Electroreduction of CO2 to ethylene offers a promising route for renewable electricity storage, yet achieving high ethylene selectivity at industrial current densities remains challenging due to the large energy barrier for C–C coupling. Here, we report a “MOF-assisted in situ doping” strategy to introduce the oxophilic nonmetal phosphorus (P) into the copper oxide (CuO) lattice, constructing a localized Cu–P dual-site adsorption configuration for the key *OCCHO intermediate. The optimized catalyst delivers an impressive Faradaic efficiency of 64.6% for ethylene with a partial current density of 646 mA cm-2. Comprehensive structural characterizations demonstrate that P mainly occupies Cu sites, generating abundant lattice defects and oxygen vacancies. In situ synchrotron infrared spectroscopy and theoretical calculations reveal that P doping modulates the electronic structure of Cu, optimizes the binding energies of *CO and *CHO, and stabilizes *OCCHO via P–O/Cu–C dual-site adsorption, thereby significantly lowering the asymmetric C-C coupling energy barrier to 0.74 eV. This work highlights a dual-site microenvironment regulation strategy for CO2-to-ethylene electroreduction.
Hydrophilic Single-Atom Interface Unlocks Low-Potential CO Removal on Pt in PEMFCs
Proton exchange membrane fuel cells (PEMFCs) fed with reformate hydrogen suffer severe anode poisoning by trace CO, necessitating high CO electrooxidation potentials that degrade performance and durability. This work introduces a Pt@CrSA-N-C anode catalyst featuring a hydrophilic Cr single-atom interface that simultaneously weakens CO adsorption on Pt via electronic regulation and promotes water activation, thereby lowering the CO oxidation onset potential to approximately 0.13 V vs. RHE. The onset potential was determined by two independent methods: the first potential at which the background-corrected current exceeds 0 mA cm-2 during CO oxidation reaction tests in a three-electrode system, and the potential at which the forward scan current exceeds the N2 background current in CO-stripping voltammetry. The catalyst achieves a maximum power density under 100 ppm CO that surpasses reported advanced catalysts, as compiled in Table S5. Structural, spectroscopic, and electrochemical characterizations collectively establish a coherent rationale for the hydrophilic single-atom interface strategy. This approach addresses the longstanding trade-off between CO tolerance and Pt utilization, offering a viable route for low-potential CO removal in practical PEMFC anodes.
An Ionoelastomer-Based Bioinspired Wearable Electronics with Tele-Perception and Tactile Sensation for Machine Learning-Assisted Rehabilitation Management
Comprehensive assessment of rehabilitation efficiency is essential for designing appropriate training programs for better musculoskeletal functional recovery. Existing contact-receptor-dependent rehabilitation assessment systems mostly focus on assessing the restoration of muscle function by evaluating grip strength or joint flexion angle; however, parameters reflecting neuromuscular synergistic function are always overlooked. Herein, we develop an ionoelastomer-based soft artificial electroreceptor (SAER) that integrates tele-perception and tactile sensation to track the rehabilitation process, collecting signals related to approaching speed and grip strength sequentially. The SAER uses polyurethane ionoelastomer incorporated with quasi-solid conductive salt as the electric field receptor, and is integrated on a rehabilitation-training ball after assembly to establish an untethered detection device; this enables the remote capture of hand approaching parameter within a 9 cm range, followed by the quantification of grip strength when contacting and grasping. Furthermore, a data-driven assessment system is established by integrating machine learning, which accurately classifies rehabilitation efficiency into six levels; it supports for rehabilitation evaluation and training programs adjustment. Overall, the SAER-based rehabilitation management system establishes a paradigm that synergistically evaluating parameters corresponding to neuromuscular functional restoration and holds strong potential for home-based active rehabilitation for minimizing dependence on frequent clinical supervision.
Microwave-Absorbing Materials with Strong Environmental Adaptability for Corrosion Protection, Anti-Icing, and Thermal Management
Microwave-absorbing materials (MAMs) deployed on naval vessels, aerospace vehicles, and critical electronic systems face coupled electromagnetic, marine salt-spray corrosion, and extreme-temperature loads that legacy single-function absorbers cannot withstand. This review consolidates progress on three environmentally adaptive MAM classes: corrosion-protective, anti-icing, and thermal-management absorbers. The electromagnetic loss and impedance-matching fundamentals are first established, then the synergistic mechanisms, design strategies, and characterization protocols for each class are examined against representative material systems and their measured performance. The analysis identifies a shared design logic—multiscale hierarchical architecture, interfacial polarization engineering, and multifunctional phase integration—while distinguishing the divergent protection mechanisms: barrier and passivation effects for corrosion, surface-energy and latent-heat regulation for anti-icing, and phonon–electron transport decoupling for thermal management. Persistent bottlenecks include the trade-off between impedance matching and protective-layer density, the absence of standardized coupled-field test protocols, and the scarcity of long-term salt-spray and thermal-cycling durability data. Future directions are delineated: intelligent self-adaptive absorbers, multiphysics-coupled simulation frameworks, and environmentally benign multifunctional integration. The review provides a theoretical and technical basis for the design, construction, and engineering scale-up of next-generation high-performance absorbers for aerospace, electronic, and marine equipment.